Abbvie Inc
NYSE:ABBV
Abbvie Inc
Other Liabilities
Abbvie Inc
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Other Liabilities
$32.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
17%
|
CAGR 10-Years
25%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Liabilities
$3.3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
26%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Liabilities
$7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
9%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Liabilities
$1.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
62%
|
CAGR 10-Years
32%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Liabilities
$980.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
17%
|
|
Seagen Inc
NASDAQ:SGEN
|
Other Liabilities
$129.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
68%
|
CAGR 10-Years
-1%
|
See Also
What is Abbvie Inc's Other Liabilities?
Other Liabilities
32.3B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Liabilities amounts to 32.3B USD.
What is Abbvie Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
25%
Over the last year, the Other Liabilities growth was 5%. The average annual Other Liabilities growth rates for Abbvie Inc have been 5% over the past three years , 17% over the past five years , and 25% over the past ten years .